Bavarian Nordics vaccinekandidat mod chikungunya er blevet tildelt fremskyndet vurdering af Det Europæiske Lægemiddelagentur
February 23, 2024 01:35 ET
|
Bavarian Nordic A/S
Fremskyndet vurdering muliggør en kortere behandlingstid for godkendelsesansøgningen hos EMA.Bavarian Nordic forventer at indsende ansøgning om markedsføringstilladelse for CHIKV VLP til EMA i...
Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency
February 23, 2024 01:35 ET
|
Bavarian Nordic A/S
Accelerated assessment allows for a shorter review period with EMA.Bavarian Nordic is on track to submit its Marketing Authorisation Application for CHIKV VLP to EMA during H1 2024. ...
Bavarian Nordic leverede rekordresultat i 2023
February 21, 2024 02:13 ET
|
Bavarian Nordic A/S
De foreløbige resultater for 2023 overstiger de seneste forventninger og udgør selskabets bedste økonomiske resultater nogensinde, hvilket er en følge af ekstraordinær vækst inden for rejsevacciner og...
Bavarian Nordic delivered record financial results in 2023
February 21, 2024 02:13 ET
|
Bavarian Nordic A/S
Preliminary 2023 results exceed the latest guidance and represent the best-ever financial result in the Company’s history driven by extraordinary growth in travel health and a surge in smallpox/mpox...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
December 13, 2023 16:42 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 13. december 2023 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
December 13, 2023 16:42 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, December 13, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding...
Bavarian Nordic iværksætter nyt incitamentsprogram for koncernledelsen og udvalgte medarbejdere
December 13, 2023 16:33 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 13. december 2023 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at bestyrelsen har besluttet at etablere et nyt langsigtet incitamentsprogram for koncernledelsen og udvalgte...
New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic
December 13, 2023 16:33 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, December 13, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a new long-term incentive program for Executive Management...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
November 30, 2023 15:00 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 30. november 2023 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
November 30, 2023 15:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 30, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding...